Pandemic Resilience, Supply & R&D Agreement for mRNA vaccines
The contract is to establish UK-based mRNA vaccine development and manufacturing capability to support the UK's preparedness and resilience for future pandemics and health emergencies. The objective of security of supply in such circumstances is to be met by the construction of a mRNA manufacturing facility sited within the UK which will work alongside UK-based fill/finish providers to supply vaccines. In addition, the contract also includes certain commitments for the supplier to invest in R&D in the field of mRNA...
Buyer
Department of Health and Social Care
Value
£1
Published
16 Jan 2023
Closes
19 Dec 2022
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Other
Category
Goods
Contract starts
20 Dec 2022
Contract ends
19 Dec 2032
CPV classifications
73300000
Design and execution of research and development
Lots
Lot default Pandemic Resilience, Supply & R&D Agreement for mRNA vaccines
£1
The contract is to establish UK-based mRNA vaccine development and manufacturing capability to support the UK's preparedness and resilience for future pandemics and health emergencies. The objective of security of supply in such circumstances is to be met by the construction of a mRNA manufacturing facility sited within the UK which will work alongside UK-ba...
Delivery: United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
16 Jan 2023
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.